R M A Packer
Clinical Risk Factors Associated with Anti-Epileptic Drug Responsiveness in Canine Epilepsy
Packer, R M A; Shihab, N K; Torres, B B J; Volk, H A
Authors
N K Shihab
B B J Torres
H A Volk
Abstract
The nature and occurrence of remission, and conversely, pharmacoresistance following epilepsy treatment is still not fully understood in human or veterinary medicine. As such, predicting which patients will have good or poor treatment outcomes is imprecise, impeding patient management. In the present study, we use a naturally occurring animal model of pharmacoresistant epilepsy to investigate clinical risk factors associated with treatment outcome. Dogs with idiopathic epilepsy, for which no underlying cause was identified, were treated at a canine epilepsy clinic and monitored following discharge from a small animal referral hospital. Clinical data was gained via standardised owner questionnaires and longitudinal follow up data was gained via telephone interview with the dogs’ owners. At follow up, 14% of treated dogs were in seizure-free remission. Dogs that did not achieve remission were more likely to be male, and to have previously experienced cluster seizures. Seizure frequency or the total number of seizures prior to treatment were not significant predictors of pharmacoresistance, demonstrating that seizure density, that is, the temporal pattern of seizure activity, is a more influential predictor of pharmacoresistance. These results are in line with clinical studies of human epilepsy, and experimental rodent models of epilepsy, that patients experiencing episodes of high seizure density (cluster seizures), not just a high seizure frequency pre-treatment, are at an increased risk of drug-refractoriness. These data provide further evidence that the dog could be a useful naturally occurring epilepsy model in the study of pharmacoresistant epilepsy.
Citation
Packer, R. M. A., Shihab, N. K., Torres, B. B. J., & Volk, H. A. (in press). Clinical Risk Factors Associated with Anti-Epileptic Drug Responsiveness in Canine Epilepsy. PLoS ONE, 9(8), e106026. https://doi.org/10.1371/journal.pone.0106026
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 29, 2014 |
Deposit Date | Nov 11, 2014 |
Publicly Available Date | Feb 11, 2019 |
Journal | PLoS One |
Electronic ISSN | 1932-6203 |
Publisher | Public Library of Science |
Peer Reviewed | Peer Reviewed |
Volume | 9 |
Issue | 8 |
Pages | e106026 |
DOI | https://doi.org/10.1371/journal.pone.0106026 |
Public URL | https://rvc-repository.worktribe.com/output/1405187 |
Additional Information | Corporate Creators : Minas Gerais |
Files
8583.pdf
(159 Kb)
PDF
You might also like
Re-evaluating the placebo response in recent canine dietary epilepsy trials
(2024)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search